CytoDyn Inc. (CYDY)
USD 0.21
(3.13%)
USD 0.21
(3.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 266 Thousand | - | - | - |
| Cost of Revenue | 29 Thousand | 175 Thousand | 53 Thousand | 1.79 Million | 2.03 Million | 1.24 Million |
| Gross Profit | -29 Thousand | -175 Thousand | 213 Thousand | -1.79 Million | -2.03 Million | -1.24 Million |
| Operating Expenses | 18.05 Million | 40.4 Million | 72.12 Million | 94.54 Million | 74.64 Million | 55.85 Million |
| Selling, General and Administrative Expenses | 10.78 Million | 17.13 Million | 44.3 Million | 34.32 Million | 19.97 Million | 12.11 Million |
| Research and Development Expenses | 7.24 Million | 2.63 Million | 27.04 Million | 58.43 Million | 52.63 Million | 42.49 Million |
| Other Expenses | 29 Thousand | -20.63 Million | 781 Thousand | 1.79 Million | 2.03 Million | 1.24 Million |
| Cost and Expenses | 18.05 Million | 40.57 Million | 72.18 Million | 94.54 Million | 74.64 Million | 55.85 Million |
| Operating Income | -18.05 Million | -40.57 Million | -71.91 Million | -104.59 Million | -74.64 Million | -55.85 Million |
| Interest Expense | 8.67 Million | 25.18 Million | 52.44 Million | 19.34 Million | 16.87 Million | 2.85 Million |
| Income Tax Expense | - | 12.99 Million | 77.34 Million | 19.34 Million | 17.37 Million | -2.82 Million |
| Earnings before Tax | -49.84 Million | -79.82 Million | -210.82 Million | -154.67 Million | -124.4 Million | -59.01 Million |
| Net Income | -49.84 Million | -79.82 Million | -288.16 Million | -174.01 Million | -141.78 Million | -56.18 Million |
| Earnings Per Share Basic | -0.05 | -0.10 | -0.43 | -0.30 | -0.34 | -0.21 |
| Earnings Per Share Diluted | -0.05 | -0.10 | -0.43 | -0.30 | -0.34 | -0.21 |
| Weighted Average Shares Outstanding | 969.5 Million | 836.52 Million | 676.9 Million | 587.59 Million | 421.07 Million | 272.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 969.5 Million | 836.52 Million | 676.9 Million | 587.59 Million | 421.07 Million | 272.04 Million |
| Gross Margin | - | - | 0.80 | - | - | - |
| EBIT Margin | - | - | -301.69 | - | - | - |
| Profit Margin | - | - | -1083.32 | - | - | - |
| EBITDA | -18.02 Million | -40.4 Million | -192.54 Million | -92.75 Million | 2.03 Million | -54.45 Million |
| Earnings Before Tax Margin | - | - | -270.35 | - | - | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | - | 50 Thousand | - | - | - | - |
| Cost of Revenue | 29 Thousand | 4000.00 | 7000.00 | 8000.00 | 10 Thousand | 175 Thousand |
| Gross Profit | -29 Thousand | 46 Thousand | -7000.00 | -8000.00 | -10 Thousand | -175 Thousand |
| Operating Expenses | 18.02 Million | 6.63 Million | 3.41 Million | 3.39 Million | 4.61 Million | 40.4 Million |
| Selling, General and Administrative Expenses | - | 3.03 Million | 2.75 Million | 2.31 Million | 2.68 Million | - |
| Research and Development Expenses | - | 3.59 Million | 650 Thousand | 1.07 Million | 1.91 Million | - |
| Other Expenses | 29 Thousand | 4000.00 | 7000.00 | 8000.00 | 10 Thousand | -20.63 Million |
| Cost and Expenses | 18.05 Million | 6.63 Million | 3.41 Million | 3.39 Million | 4.61 Million | 40.57 Million |
| Operating Income | -18.05 Million | -6.63 Million | -3.41 Million | -3.39 Million | -4.61 Million | -40.57 Million |
| Interest Expense | -31.78 Million | 1.27 Million | 1.56 Million | 1.3 Million | 1.59 Million | 25.18 Million |
| Income Tax Expense | - | -24.79 Million | 11.92 Million | 1.3 Million | 11.57 Million | 12.99 Million |
| Earnings before Tax | -49.84 Million | -16.78 Million | -11.92 Million | -9.56 Million | -11.57 Million | -79.82 Million |
| Net Income | -49.84 Million | -16.78 Million | -11.92 Million | -9.56 Million | -11.57 Million | -79.82 Million |
| Earnings Per Share Basic | - | -0.02 | -0.01 | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | - | -0.02 | -0.01 | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 969.5 Million | 1 Billion | 982.2 Million | 958.98 Million | 923.58 Million | 836.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 969.5 Million | 1 Billion | 982.2 Million | 958.98 Million | 923.58 Million | 836.52 Million |
| Gross Margin | - | 0.92 | - | - | - | - |
| EBIT Margin | - | -132.60 | - | - | - | - |
| Profit Margin | - | -335.74 | - | - | - | - |
| EBITDA | - | -6.63 Million | -7.84 Million | -5.82 Million | -7.88 Million | - |
| Earnings Before Tax Margin | - | -132.68 | - | - | - | - |
BLUECLOUDS
ETIL
012690
WNBD
SOZAP
0SOM